Our Take
The device works in mice and solves a real engineering problem (light interference with electrophysiology), but the leap from causal mapping in rodent cortex to human disease treatment remains years away.
Why it matters
Neuroscience has been split between observation (electrophysiology) and intervention (optogenetics) for decades. A single instrument that does both simultaneously lets researchers directly test whether specific neurons cause behavior or disease, rather than infer causation. This matters now because neurological disorders like Alzheimer's and schizophrenia have resisted treatment; understanding actual circuit mechanics is prerequisite to targeting them.
Do this week
Neuroscience labs using electrophysiology: evaluate whether your current experimental design could benefit from optogenetic perturbation in the same session, then contact UCL or commercial partners about probe access before committing to separate-instrument experiments.
Researchers Integrated Recording and Stimulation into One Probe
UCL scientists have developed Neuropixels Opto, a single brain probe that combines high-resolution electrophysiology with optogenetics. The device packs 960 electrical recording sites and two sets of 14 light emitters onto a 70-micrometer-wide, 1-centimeter-long shank. It delivers blue and red light to activate or silence specific neurons while simultaneously measuring the electrical activity of hundreds of cells.
The technical barrier was formidable: light used for optogenetic stimulation historically interferes with the sensitive electrical recordings needed for precise neural measurement, especially deep in the brain where light scatters. Neuropixels Opto solves this by integrating both capabilities into a single device, allowing spatially targeted light delivery without disrupting the recording signal.
Early experiments in mice revealed a striking finding. Karolina Socha, a research fellow at UCL's Institute of Ophthalmology, discovered that cortical neurons operate more independently than expected. "Up to now, we thought that neurons are so interconnected that there would be no way to activate some of them without activating many others," Socha said. The probes revealed neurons can operate "not only in concert but also rather independently." The work appears in Nature Methods.
Causation, Not Correlation, for Circuit Biology
Neuroscience has historically approached neural circuits with two separate tools. Electrophysiology records what neurons do. Optogenetics allows researchers to activate or silence specific cell types. Neither alone answers the hardest question: does activating neuron X actually cause behavior Y, or is it just correlated?
Neuropixels Opto closes that gap in a single experiment. By recording the downstream effects of targeted optogenetic stimulation in real time, researchers can now directly test causal relationships within neural circuits. Matteo Carandini, professor at the UCL Institute of Ophthalmology, framed it plainly: "This makes it possible, for the first time, to directly test how specific neurons influence the activity of surrounding circuits."
That capability matters for disease. Many neurological and psychiatric disorders—schizophrenia, Alzheimer's disease, Parkinson's disease—involve disrupted communication between neurons. A tool that reveals how circuits malfunction in disease models, compared to healthy brains, provides a rational foundation for targeted intervention rather than systemic drugs that affect the entire brain.
The limitation is scope. Current work is in mice. Human translation requires miniaturization, biocompatibility validation, and proof that findings in rodent cortex predict outcomes in human patients. That gap is real and will take years to close.
Evaluate Your Experimental Design Against New Possibilities
If your lab currently separates electrophysiology and optogenetics into different experiments, you now have a tool to collapse that workflow. Assess whether your research questions require simultaneous measurement and manipulation. Check with UCL or commercial probe manufacturers about availability and lead times before designing the next experiment around separate instruments.
For researchers focused on circuit dynamics in disease models, the ability to test causation in the same session reduces experimental variance and accelerates hypothesis testing. Plan for a learning curve; the probe is new and best practices are still being established.